Here we provide the first evidence, to our knowledge, that estradiol (E 2) affects learning and memory via the newly discovered estrogen receptor ␤ (ER␤). In this study, ER␤ knockout (ER␤KO) and wild-type littermates were tested for spatial learning in the Morris water maze after ovariectomy, appropriate control treatment, or one of two physiological doses of E 2. Regardless of treatment, all wild-type females displayed significant learning. However, ER␤KOs given the low dose of E 2 were delayed in learning acquisition, and ER␤KOs administered the higher dose of E2 failed to learn the task. These data show that ER␤ is required for optimal spatial learning and may have implications for hormone replacement therapy in women.
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T he steroid hormone estradiol (E 2 ) either is required for or significantly modulates many behaviors, including cognitive behaviors (1) (2) (3) (4) (5) (6) (7) (8) (9) . Learning tasks that involve reference memory tend to be impaired by E 2 (1, 7, 8) . In contrast, low levels of E 2 may facilitate working memory (5, 9) . In women, changes in ability on visuospatial tasks and memory recall over the menstrual cycle have been documented (10, 11) . Also, beneficial effects of estrogen replacement on cognition have been noted in normally aging women (12, 13) and in women suffering from dementia associated with Alzheimer's disease (14, 15) .
How estrogen acts on learning and memory is not clear. Estrogen binding has been reported throughout the rodent brain, including the hippocampus and cortex (16) . Both characterized nuclear estrogen receptors (ER␣ and -␤) are present in extrahypothalamic regions (17, 18) . In addition, in vitro work suggests that estrogen acts in a nongenomic fashion in hippocampal tissues (19, 20) . Mice lacking functional ER␣ have severe deficits in several aspects of reproduction, including behavior (21) (22) (23) (24) . On the other hand, ER␤ knockout mice (ER␤KO) are subfertile, and sexual behavior is normal (25, 26) . Thus, there has been speculation that ER␤ regulates estrogen's nonreproductive functions in the central nervous system (21, 27, 28) .
Here we describe our work on spatial learning in female ER␤KO mice. When treated with doses of E 2 that do not affect learning in wild-type (WT) littermates, ER␤KO mice had impaired ability to escape from the Morris water maze. Interactions between ER␣ and -␤ may contribute to the learning response; to test the hypothesis that lack of ER␤ influences the level of ER␣ protein, mouse brains were examined for ER␣ immunoreactivity (ER␣-ir), with emphasis on the hippocampus (HIPP).
Methods
Animals. Female mice (ages 5-7 mos) were of mixed 129͞J and C57BL͞6J background. Subjects were generated by crossing heterozygotic mating pairs carrying a single copy of the disrupted ER␤ gene (25) . The resulting offspring were genotyped by PCR amplification of tail DNA. WT and ER␤ disrupted (ER␤KO) littermates were used in these studies. The ER␤ gene disruption was created by Neo insertion into exon 3 (25) , thus the following three primers were used: one from intron 2 (5Ј-GGAGTAGAAACAAGCAATCCAGACATC-3Ј), another from the 3Ј end of the Neo insert (5Ј-GCAGCCTCTGTTCCA-CATACACTTC-3Ј), and a third from exon 3 (5Ј-AGAATGT-TGCACTGCCCCTGCTGCT-3Ј). A 665-bp band (intron 2 and exon 3 primers) was amplified for homozygous WT mice, a 500-bp band (intron 2 and Neo primers) for homozygous mutant mice, and both bands for heterozygous mice.
After surgery, mice were individually housed in polycarbonate cages, maintained on a 12:12-h light͞dark cycle (lights off at 1800 h Eastern Daylight Time), and received food (Purina mouse chow no. 5001) and water ad libitum.
Surgery and Hormone Administration. All mice (WT, n ϭ 25, and ER␤KO, n ϭ 30) were ovariectomized (OVX) under ketamine͞ xylazine anesthesia (20͞2 mg per 25 g body weight). At time of surgery, each female was randomly assigned to a treatment group and received either an E 2 17␤-filled or an empty Silastic implant (controls). E 2 implants were made in Silastic tubing via two methods. One type of implant was made by packing 5 mm of crystalline 17␤-E 2 into Silastic tubing (i.d. 1.02 ϫ o.d. 2.16 mm). We anticipated that this would yield a relatively high dose of E 2 in plasma. The other implants were produced by first dissolving 17␤-E 2 in sesame oil vehicle (2.5 g͞0.025 ml) and then infusing 0.025 ml into a Silastic implant (i.d. 1.02 ϫ o.d. 2.16 mm). Both ends of the Silastic tubing were glued with adhesive. Dilution of E 2 in sesame oil was done to create a relatively low concentration of E 2 in plasma. Thus a total of six groups were formed with 8-13 individuals per group. Silastic implants were administered s.c. and were placed in the midscapula region.
Ten days after surgery, each animal was tested for behavior by observers that were uninformed as to the genotype of the animals. Three to four days after behavior testing was concluded mice were deeply anesthetized with sodium pentobarbital (10 mg͞kg) and quickly decapitated. Blood was collected and spun, and plasma frozen for E 2 assay. Brains were rapidly removed and immersion fixed in 5% acrolein. Uteri were removed, cleaned of fat and connective tissue, and weighed. Animal care was conducted in accordance with the University of Virginia Animal Care and Use Committee guidelines.
Water Maze Training. Our procedures have been described in detail (8) . Briefly, each mouse was tested over 4 consecutive days before lights off during the lighted portion of the light͞dark cycle. Animals were trained in a black circular pool (120 cm in diameter) located in a lit room containing a number of two-and three-dimensional visual cues. Pool water was maintained at 23 Ϯ 2°C. A black escape platform (10.5 cm in diameter) was submerged 1.5 cm below the surface of the water. The location of the platform remained the same throughout the 4-day training period.
On the first day, each mouse was given a 30-sec free swim and then assisted to the platform where she remained for a 30-sec rest. This pattern was repeated four times, once from each equidistant release site. Training consisted of three blocks of four trials each for 4 consecutive days. Each trial lasted for 60 sec or ended sooner if the mouse reached the submerged platform, thus escaping from the swim maze. If a mouse failed to find the platform in 60 sec, she was assisted to it. Between trials, each mouse rested on the platform for 20 sec. Mice were released in random order from one of the four release sites. Data collected for each trial were: latency to escape from the water maze (find the submerged escape platform), and whether the mouse succeeded in finding the platform at all during the 60-sec trial. After data were collected and analyzed for the spatial version of the task, a separate group of five ER␤KO mice were run on the cued version. In this test, the escape platform is 5 cm above the surface of the water and is clearly marked with a large white flag. All competing visual cues in the room are removed. The rationale for this test is that mice that failed to find the escape platform in the spatial test should be able to locate the platform when it is visible. Because this task is relatively simple to learn, it is conducted only over a 3-day interval.
Immunocytochemisty. Because the largest behavioral effects were noted between the control females and those in the high E 2 dose group, we limited the histological analysis to brains collected from these animals (both genotypes, n ϭ 6-11 per group). Brains fixed in 5% acrolein were cryoprotected overnight in 30% sucrose at 4°C and quickly frozen by using 2-methyl butane cooled in dry ice. Brains were stored at Ϫ70°C until they were sectioned.
Frozen brains were sectioned coronally at 30 m and divided into a series of three wells. One well of tissue (one-third of the sections collected) was processed by using a rabbit antiserum specific to ER␣ (C1355) made against the last 14 amino acids of the C-terminal region of the ER␣ protein (29) . There is no homology between this region of ER␣ and -␤, respectively, thus there is no crossreactivity with ER␤. We have validated the use of this antiserum in mouse brain previously (30) .
Immunoreactivity was visualized by using the Vector Elite ABC method (Vector Laboratories). Our methods have been described in detail (30) . Nickel intensified diaminobenzidine (DAB) solution (0.25% nickel ammonium sulfate͞0.05% DAB), activated by 0.001% hydrogen peroxide was used as the chromogen. Sections were rinsed, mounted onto gelatin coated slides, dehydrated, and coverslipped.
Immunocytochemical Data Analysis. An observer uninformed as to the genotype and treatment of the animals scored the tissues. Immunoreactive cells were visualized by using an Olympus (New Hyde Park, NY) BX60 microscope attached to an Optronics charge-coupled device camera. The image analyses were conducted with METAMORPH software (Universal Imaging, Media, PA). The number of ER␣-ir neurons was counted. The images were captured and saved for each animal from unilateral matched sections of each brain by using well-defined landmarks and a mouse brain atlas (figure 54 of ref. 31; interaural coordinate ϭ 1.00 mm, Bregma ϭ Ϫ2.80 mm). Absolute cell counts and counts per microns squared were made. The landmarks include the shape and size of the lateral ventricles and the cerebral peduncle and the periaqueductal gray. Two regions were quantified in the same section. The regions included the total dorsal-to-ventral extent of the dentate gyrus, CA1-3 in the hippocampus (referred to as HIPP) and the amygdalohippocampal area (AHIA; Fig. 1 ).
E2 Assay. All samples were assayed in singlicate in a single assay. A commercial assay kit (Ultra-Estradiol, Diagnostic Systems Laboratories, Webster, TX) was used. The theoretical sensitivity of the assay is 0.6 pg͞ml, and the standard curve ranges from 1.5 to 150 pg͞ml. Maximum binding was 28%, and intraassay variability was 10.4%.
Statistics. All behavior data were analyzed by repeated-measures ANOVA by using genotype, E 2 dose, and test day as the treatment factors. Specific genotype differences were analyzed over time and on specific test days with two-way ANOVA. We conducted the behavioral analyses on the average escape latency per day for each subject. In addition, we calculated a success score based on the number of times each day the mouse was able to locate the platform during each 60-sec trial. The maximum score was 12, and the minimum was 0. The immunocytochemical data were subjected to three-way ANOVA. The three factors were: immunocytochemical run (sections were developed in two runs separated by several months), genotype, and hormone treatment. E 2 concentrations in plasma and uterine weights were analyzed via two-way ANOVA. Bonferroni's planned comparisons corrected for multiple comparisons were conducted to assess group differences.
Results

E2 Treatment Impedes Escape Behavior in ER␤KO Mice
. OVX ER␤KO mice treated with E 2 escaped from the Morris water maze more slowly than WT littermates (Fig. 2) . A two-way repeated-measures ANOVA revealed significant effects of hormone dose [F(2,220) ϭ 5.60, P Ͻ 0.0065] and genotype [F(1,220) ϭ 4.47, P Ͻ 0.04] on latency to find the submerged escape platform. When control OVX WT and ER␤KO mice were compared, no differences were found in escape latencies for any of the testing days [F(1,17) ϭ 0.54, 0.54, 0.01, and 0.36 on days 1, 2, 3, and 4, respectively]. However, when females that received E 2 were examined, an effect of genotype was found [F(1,152) ϭ 9.23, P Ͻ 0.005], as well as a three-way interaction between genotype, hormone dose, and test day [F(3,152) ϭ 4.06, P Ͻ 0.01, Fig. 2 Fig. 2] .
Among WT females, no differences in escape latencies were attributed to hormone treatment [F (2, In WT females, an interaction between hormone dose and test day was noted [F(6,100) ϭ 3.19, P Ͻ 0.01]. On test day 2, WT females treated with the high E 2 dose had lower success scores than OVX females. Both hormone dose effects [F(2,120) ϭ 11.53, P Ͻ 0.00025] and an interaction between test day and dose [F(6,120) ϭ 2.27, P Ͻ 0.045] were noted in ER␤KO females. On test days 2, 3, and 4, females in the high E 2 group had significantly lower success scores than OVX control females (P Ͻ 0.05).
E 2 Does Not Inhibit Escape in the Cued Water Maze Task.
To assess motor ability and general motivation to exit the water maze, we conducted a cued test with five ER␤KO individuals. All were OVX and treated with the high E 2 dose, as described in Methods. Females displayed a significant decrease in latency to find the platform [F(2,15) ϭ 21.83, P Ͻ 0.0006] and an increase in success scores [F(2,15) ϭ 11.17, P Ͻ 0.005] over the 3 testing days. In both measures, the differences lie between the first test day and the other 2 days (P Ͻ 0.05). By the second day of testing, females found the platform in less than 20 sec and were successful in their escape attempts 11 of 12 times.
Estrogen Treatment Affects Uterine Weights and Concentrations of E2
in Plasma. Hormone treatment, but not genotype, had a significant effect on uterine weights [F(2,64) ϭ 47.99, P Ͻ 0.000001]. Uterine weights in each treatment group differed significantly from the other two groups (P Ͻ 0.05). The means (in milligrams) and SEM for uteri collected from females in each hormone group were as follows: OVX ϭ 24.56 Ϯ 2.37; OVX ϩ E 2 oil-diluted implant ϭ 88.12 Ϯ 13.30; OVX ϩ crystalline E 2 implant ϭ 197.33 Ϯ 12.44. In A, data from OVX mice (n ϭ 8 WT, n ϭ 9 ER␤KO) are compared. B features data from OVX control mice receiving a low dose of E 2 (n ϭ 9 WT, n ϭ 8 ER␤KO). Finally, in C, data from females receiving the higher dose of E 2 are shown (n ϭ 8 WT, n ϭ 13 ER␤KO).
* , significantly different from WT females (comparisons on the same day).
In addition, hormone treatment had the desired effect of creating different concentrations of E 2 in plasma [F(2,51) ϭ 46.62, P Ͻ 0.000001]. The crystalline E 2 -17␤-packed implant yielded a blood concentration that averaged 98.05 Ϯ 6.00 (SEM) pg͞ml. This concentration is similar to that measured in plasma of C57BL͞6J mice during proestrous (ref. 32 ; E.F.R., unpublished data). This E 2 concentration differs significantly from the measured plasma levels in OVX controls (16.1 Ϯ 9.3 pg͞ml) and in OVX mice that received the oil-diluted dose of E 2 (13.4 Ϯ 3.6 pg͞ml). It is clear from behavioral data and uterine weights that control OVX females and OVX mice treated with the low dose of E 2 were experiencing different levels of E 2 in the blood. However, because the low E 2 dose yields plasma E 2 concentrations close to the bottom end of the physiological range, we are not surprised that the assay did not show a significant difference in plasma E 2 levels among females in these groups. Moreover, this concentration (13.4 pg͞ml) is similar to that measured during diestrus in ovary-intact mice (32) . Table 1 ). In the AHIA, no significant effects of immunocytochemical run, hormones, or genotype were noted [F(1,36) ϭ 0.01, 2.10, 0.00, respectively]. Intensely stained ER␣-ir cells were present in the AHIA (Fig. 4) . In the hippocampus, many lightly stained cells were present throughout the region, but only the darkly immunoreactive cells, similar in intensity to those counted in the AHIA, were counted (Fig. 4) . Most of these ER␣-ir cells were noted in the ventral portion of the granular layer of the dentate gyrus.
ER␤ Affects Expression of ER␣-ir in
Discussion
Our data show that two doses of E 2 , which yield plasma concentrations similar to those experienced during the mouse estrous cycle, either completely blocked (high dose) or delayed (low dose) learning acquisition in the spatial water maze task in ER␤KO but not in WT littermates. Thus, the lack of ER␤ severely impairs spatial learning in mice. Because the doses of E 2 were within the physiological range, we infer that ER␤ is actively involved in reference memory formation during the normal estrous cycle. In contrast, our previous work with an even higher dose of E 2 than used here showed that water maze learning was impaired in WT but not in ER␣KO females (8) . Together, these data suggest that the inhibitory effect of E 2 on learning is mediated by ER␣, and the lack of ER␤ increases sensitivity to the negative consequences of E 2 on reference memory, particularly spatial learning. Thus, when ER␤ is not functional, the actions of E 2 on ER␣ are ''unmasked'' and are more pronounced than under conditions where both ERs are responsive.
One way to describe this relationship is to examine E 2 dosedependent effects on behavior in WT and ER␤KO females. In WT females, there was only a single time point when a difference in behavior could be attributed to concentrations of E 2 in plasma. On day 2, success scores for OVX WT mice were significantly higher than scores for females in the high E 2 dose group. In contrast, ER␤KO females treated with the high E 2 dose had lower success scores than their OVX counterparts on all except the first day of the task. In addition, in ER␤KO but not in WT females, there were significant effects of E 2 dose on latencies to escape from the maze. Slower escape latencies accompanied poor success scores in females receiving the high E 2 dose. The low E 2 dose also had behavioral effects in ER␤KOs; however, these effects were transient. On the first 2 days of testing, ER␤KO females in the low E 2 group were slower to escape than untreated OVX mice. On the last day, ER␤KOs in the low E 2 group were faster to escape than their counterparts in the high E 2 dose group. Thus, in the absence of ER␤, treatment with a low dose of E 2 delayed spatial learning, whereas exposure to the high E 2 dose blocked learning acquisition during the 4-day test. Importantly, these dosage effects of E 2 within the physiological range are apparent only in the absence of functional ER␤. ER␤ may also serve to protect ER␣ protein from downregulation by E 2 , perhaps by binding available ligand. Here we show that the numbers of ER␣-ir-positive nuclei after estrogen treatment were significantly reduced only in ER␤KO mice. Likewise, in regions of the hypothalamus such as the ventromedial nucleus, preoptic area, and the arcuate nucleus in ER␤KO, but not in WT females, this same down-regulation of E 2 on ER␣-ir cells has been reported (33) . In the hippocampus, reduced ER␣ could influence the levels or activity of many growth factors and͞or neurotransmitters known or suspected to be involved in learning, including acetylcholine, neural growth factors, and their receptors (34) (35) (36) (37) .
Several studies have documented direct interactions between ER␣ and -␤ both in vitro (38) (39) (40) and in vivo (33, 41, 42) , and colocalization of the two receptor forms occurs in specific subsets of neurons throughout the brain (43, 44) . ER␣ and -␤ can form heterodimers in vitro and, in cell transfection studies, ER␤ functionally suppresses ER␣ transcriptional activity (39, (45) (46) (47) . ER␤ has been postulated to act as a repressor to ER␣ in complicated processes such as cell growth or tumorigenesis, and changes in the ER␣͞-␤ ratio are associated with several types of cancer (48, 49) . The mechanism of estrogen action on learning is unknown but could include both genomic and nongenomic effects as well as actions mediated via other proteins or receptors. For any of these pathways, ER␤ might act as a repressor of ER␣. For example, E 2 activates the mitogen-activated protein kinase (MAPK) cascade within minutes in cortical tissue (20) and facilitates rapid initiation of kainate-induced current in individual hippocampal neurons (19) . Neither effect was blocked by the potent antiestrogen ICI 182,780. Moreover, when brain tissues from WT and ER␣KO mice were compared, extracellular signal-regulated kinases (ERK) phosphorylation was significantly enhanced in the absence of functional ER␣ (20) . Thus, ER␣ may suppress overall MAPK activity, either directly or indirectly. Recently, a G protein-coupled receptor homolog, GPR30, has been show to affect ERK activation in the absence of either ER␣ or -␤, perhaps via a nongenomic action of E 2 on growth factors (49) . It is possible that E 2 actions on the MAPK cascade may have consequences for learning when both ER␣ and -␤ are present, and these actions may be disrupted when one or both of the ERs is not available.
Another profound manner in which estrogens could affect learning and memory is via neural remodeling and plasticity. E 2 alters many aspects of hippocampal morphology, including synapse number, spine density, and astrocytic volume (50) (51) (52) . In brain, astrocytes contain ER␤ (53, 54) . Moreover, ER␤KO brains display fewer Nissl-stained neurons and increased glial fibrillary acidic protein immunoreactive cells in the medial amygdala and preoptic area, as compared with WT littermates (55) . It is well known that adult neurogenesis can be triggered by estrogen (56) , yet the ER responsible for these effects has not been identified. In addition, estrogen exposure can promote or deter apoptosis (57) , with the identity of the ER responsible for neuroprotection under debate (58, 59) . Regardless of whether ER␤ acts to reduce estrogen-related synaptogenesis, glia concentrations, prevent cell death and͞or stimulate neurogenesis, any or some of these effects may impact learning and memory.
Learning is a complex behavior, and it is possible that another behavioral phenotype of the ER␤KO mice could affect their ability to learn. Sexual behaviors have been reported to be normal in male and female ER␤KO mice (26) . In addition, although ER␣KO females required estrogen treatment to learn to avoid shock in a simple 24-h learning task, WT and ER␤KO females performed well on the task regardless of estrogen status (60) . Yet, one recent report suggests that female ER␤KO mice have elevated levels of anxiety and reduced levels of activity in open field tests (61) . We have collected similar data from OVX ER␤KO and WT female littermates given no hormone or treated with the high E 2 dose used in the current experiments (D. B. Imwalle and E.F.R., unpublished data). In our study, ER␤KO mice displayed elevated anxiety, but E 2 had no effect. Thus, although anxiety could be a contributing factor, it cannot completely explain the E 2 dose-dependent learning impairment in ER␤KOs.
Our results are compelling: WT females were able to learn a spatial task with or without E 2 replacement, but ER␤KOs could perform only when no E 2 was given. Yet there are many issues that still need to be addressed. For example, in female rats, E 2 influences learning strategies (62). Thus it is still possible that lack of ER␤ specifically influences a type or component of learning in a spatial task. Given our previous findings that ER␣KO females do not learn well in an inhibitory avoidance task (60) , it is tempting to speculate that the two ERs affect different types of learning; perhaps ER␣ is needed for emotional learning that is likely to rely on the amygdala, whereas hippocampaldependent spatial learning requires ER␤. Given the demographics of aging and increase in treatment of menopausal symptoms with estrogen replacement therapy, it would be useful to know more about the interactions and independent functions of the two ERs. These data can lead to the development of ER-specific agonists and antagonists that will be needed to ensure proper cognitive function in postmenopausal women.
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